Biomune

Biomune Company, now a core component of Ceva Animal Health, is a premier biotechnology firm specializing in the development and manufacture of advanced veterinary vaccines. Headquartered in Lenexa, Kansas, the company is renowned for its innovative viral vector technology, particularly the Vectormune platform, which provides long-lasting immunity against multiple poultry diseases. Since its acquisition by Ceva Santé Animale in 2005, Biomune has served as a global center for avian and swine biologicals, exporting products to over 70 countries. The company's portfolio includes a wide range of USDA-licensed vaccines targeting critical agricultural pathogens such as Newcastle disease, Marek's disease, and Mycoplasma bovis. Biomune continues to lead in the 'One Health' space by ensuring food security and preventing zoonotic disease transmission through high-tech animal health solutions.